iShares Biotechnology ETF $IBB Shares Bought by Southern Capital Advisors LLC

Southern Capital Advisors LLC increased its position in iShares Biotechnology ETF (NASDAQ:IBB) by 922.4% during the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 22,482 shares of the financial services provider’s stock after acquiring an additional 20,283 shares during the period. iShares Biotechnology ETF makes up 1.5% of Southern Capital Advisors LLC’s portfolio, making the stock its 19th biggest position. Southern Capital Advisors LLC owned approximately 0.05% of iShares Biotechnology ETF worth $3,246,000 at the end of the most recent quarter.

Several other hedge funds have also recently bought and sold shares of the company. Darwin Wealth Management LLC acquired a new stake in shares of iShares Biotechnology ETF in the second quarter valued at approximately $25,000. Berkshire Money Management Inc. bought a new position in iShares Biotechnology ETF in the 2nd quarter worth approximately $28,000. Financial Gravity Companies Inc. acquired a new stake in iShares Biotechnology ETF in the 2nd quarter valued at approximately $29,000. Harbor Asset Planning Inc. acquired a new stake in iShares Biotechnology ETF in the 2nd quarter valued at approximately $31,000. Finally, Trust Co. of Toledo NA OH bought a new stake in iShares Biotechnology ETF during the 2nd quarter valued at $32,000. 62.45% of the stock is currently owned by institutional investors.

iShares Biotechnology ETF Trading Down 1.0%

Shares of IBB stock opened at $172.43 on Friday. iShares Biotechnology ETF has a 1 year low of $107.43 and a 1 year high of $179.64. The stock has a fifty day moving average of $171.45 and a two-hundred day moving average of $154.60.

iShares Biotechnology ETF Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, December 19th. Investors of record on Tuesday, December 16th were issued a $0.1831 dividend. The ex-dividend date of this dividend was Tuesday, December 16th. This is an increase from iShares Biotechnology ETF’s previous quarterly dividend of $0.08. This represents a $0.73 annualized dividend and a yield of 0.4%.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.